ImmunoGen, Inc.
IMGNDelisted Feb 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000855654
ImmunoGen, Inc. was delisted on Feb 12, 2024; its insiders filed their last Form 4 on Feb 12, 2024; 327 institutions reported holding it in 13F filings for Q4 2023, worth $7.54B in total; Maverick Capital was the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding ImmunoGen, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 3 | 1 | −2 |
| Shares | 893 | 1 | −892 (−99.9%) |
| Value | $27.8K | $31 | −$27.7K (−99.9%) |
New holders (0)
Institutions that held ImmunoGen, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
None.
Sold out (2)
Institutions that held ImmunoGen, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| IFP Advisors, Inc | 830 | $25.9K |
| Mather Group, LLC. | 62 | $1.84K |